Alk Abell As Stock Today
AKBLF Stock | USD 21.35 1.05 5.17% |
PerformanceVery Weak
| Odds Of DistressLow
|
ALK-Abelló A/S is trading at 21.35 as of the 17th of February 2025. This is a 5.17 percent up since the beginning of the trading day. The stock's lowest day price was 21.35. ALK-Abelló A/S has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of February 2023 and ending today, the 17th of February 2025. Click here to learn more.
ALK-Abell AS operates as an allergy solutions company in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. Alk Abello operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 200.74 M outstanding shares. More on ALK Abell AS
Moving together with ALK-Abelló Pink Sheet
0.67 | NVO | Novo Nordisk AS | PairCorr |
0.67 | NONOF | Novo Nordisk AS | PairCorr |
0.63 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against ALK-Abelló Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ALK-Abelló Pink Sheet Highlights
President CEO | Carsten Hellmann |
Business Concentration | Biotechnology, Healthcare (View all Sectors) |
ALK Abell AS [AKBLF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ALK-Abelló A/S's market, we take the total number of its shares issued and multiply it by ALK-Abelló A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ALK-Abelló A/S classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 200.74 M outstanding shares.
ALK Abell AS has accumulated about 201 M in cash with 416 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91.
Check ALK-Abelló A/S Probability Of Bankruptcy
Ownership AllocationALK-Abelló A/S holds a total of 200.74 Million outstanding shares. Over half of ALK-Abelló A/S's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ALK-Abelló Ownership Details
ALK-Abelló A/S Risk Profiles
Mean Deviation | 0.4905 | |||
Standard Deviation | 1.48 | |||
Variance | 2.19 | |||
Risk Adjusted Performance | (0.07) |
ALK-Abelló Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ALK-Abelló A/S without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
All Next | Launch Module |
ALK-Abelló A/S Corporate Management
Henrik Jacobi | Executive VP of RandD and Member of Board of Management | Profile | |
Soren Jelert | Ex CFO | Profile | |
Miles Guralnick | Pres Inc | Profile | |
Sren Jelert | Ex CFO | Profile | |
Christian Houghton | Head Supply | Profile |
Other Information on Investing in ALK-Abelló Pink Sheet
ALK-Abelló A/S financial ratios help investors to determine whether ALK-Abelló Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALK-Abelló with respect to the benefits of owning ALK-Abelló A/S security.